follow the money—the politics of embryonic stem cell research胚胎干细胞研究的金钱政治.pdfVIP

Open access, freely available online Feature Follow the Money—The Politics of Embryonic Stem Cell Research Eugene Russo erman embryonic stem cell scientist Oliver Brustle An Intriguing Proposition faces major challenges in his lab on a daily basis that Stanford University (Stanford, California, United States Ghave little to do with science. His country’s policy of America) stem cell scientist Irv Weissman, who played on human embryonic stem cells (hESCs) is among the most restrictive in Europe. Collaborations with other countries are a key role in the multimillion dollar effort that recruited difficult. And he’s overwhelmed by the time and paperwork researchers, advocates, and Hollywood actors to support Prop necessary to comply with regulations and to apply for permits. 71, attributes the effort’s inception to a 2002 US National Brustle, an investigator at the University of Bonn (Bonn, Academy of Sciences report on cloning. It contended that Germany), often ponders the possibility of taking his work therapeutic cloning, or somatic cell nuclear transfer (SCNT), elsewhere. “I think about it every day,” he says. “Sometimes [the regulations] get to the point where they’re suffocating.” Many of his German colleagues have similar sentiments, he says. In Germany, scientists can only work on hESC lines derived in labs outside the country, and even then, only if the line was derived prior to 2002. Federal law prohibits the derivation of new hESC lines. Yet Brustle is optimistic that hESC technology, flush with research do